SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-067837
Filing Date
2014-11-13
Accepted
2014-11-13 17:09:04
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v392878_10q.htm 10-Q 748316
2 EXHIBIT 31.1 v392878_ex31-1.htm EX-31.1 9643
3 EXHIBIT 31.2 v392878_ex31-2.htm EX-31.2 9748
4 EXHIBIT 32.1 v392878_ex32-1.htm EX-32.1 5651
  Complete submission text file 0001144204-14-067837.txt   6957016

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT adhxf-20140930.xml EX-101.INS 1069035
6 XBRL TAXONOMY EXTENSION SCHEMA adhxf-20140930.xsd EX-101.SCH 38807
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE adhxf-20140930_cal.xml EX-101.CAL 31342
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE adhxf-20140930_def.xml EX-101.DEF 201181
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE adhxf-20140930_lab.xml EX-101.LAB 270608
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adhxf-20140930_pre.xml EX-101.PRE 229861
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 141219225
SIC: 2836 Biological Products, (No Diagnostic Substances)